Using endosonography to assess the effects of neoadjuvant therapy in patients with advanced esophageal cancer.

Abstract

The percentage reduction in tumor area estimated by means of endosonography reflects the histologic effectiveness of neoadjuvant therapy in patients with advanced esophageal carcinoma and may enable clinicians to predict the prognosis of the disease.